|
Glenmark Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 12951.13 | 9925.70 | 8750.15 | 9616.40 | 9213.05 |
| Other Operating Income | 260.80 | 139.83 | 0.00 | 0.00 | 72.71 |
| Total Income From Operations | 13211.93 | 10065.53 | 8750.15 | 9616.40 | 9285.76 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2230.26 | 2206.50 | 2403.51 | 2717.00 | 2488.82 |
| Purchase of Traded Goods | 1950.35 | 1221.26 | 1240.36 | 1037.87 | 879.26 |
| Increase/Decrease in Stocks | -605.43 | -163.36 | -226.04 | -410.02 | -13.67 |
| Employees Cost | 2690.41 | 2285.49 | 2167.19 | 2123.38 | 1869.74 |
| Depreciation | 425.57 | 360.81 | 430.57 | 464.74 | 355.19 |
| Other Expenses | 3136.51 | 2725.29 | 2474.13 | 2474.77 | 2204.70 |
| Total Expenses | 9827.68 | 8635.99 | 8489.73 | 8407.73 | 7784.05 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3384.25 | 1429.55 | 260.42 | 1208.67 | 1501.71 |
| Other Income | 271.54 | 102.04 | 66.83 | 357.00 | 59.47 |
| P/L Before Interest, Excpt. Items & Tax | 3655.78 | 1531.59 | 327.25 | 1565.67 | 1561.18 |
| Interest | 166.12 | 140.35 | 367.41 | 240.33 | 211.24 |
| P/L Before Exceptional Items & Tax | 3489.66 | 1391.23 | -40.16 | 1325.34 | 1349.94 |
| Exceptional Items | -1892.69 | 0.00 | -454.17 | 33.88 | -178.38 |
| P/L Before Tax | 1596.98 | 1391.23 | -494.33 | 1359.22 | 1171.56 |
| Tax | 536.35 | 348.48 | 97.87 | 578.68 | 350.47 |
| P/L After Tax from Ordinary Activities | 1060.63 | 1042.75 | -592.20 | 780.54 | 821.08 |
| Extra Ordinary Item | 0.00 | 0.00 | 372.95 | 0.00 | 0.00 |
| Net Profit/Loss For the Period | 1060.63 | 1042.75 | -219.25 | 780.54 | 821.08 |
| Net P/L After Minority Interest & Share Of Associates | 1060.63 | 1042.75 | -219.25 | 780.54 | 821.08 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 37.58 | 36.95 | -10.04 | 25.71 | 27.86 |
| Diluted EPS (Rs.) | 37.58 | 36.95 | -10.04 | 25.71 | 27.86 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 37.58 | 36.95 | -10.04 | 25.71 | 27.86 |
| Diluted EPS (Rs.) | 37.58 | 36.95 | -10.04 | 25.71 | 27.86 |
| | | | | | |
| PBITOE Margin (%) | 25.61 | 14.20 | 2.97 | 12.56 | 16.17 |
| PBTE Margin (%) | 26.41 | 13.82 | -0.45 | 13.78 | 14.53 |
| PBT Margin (%) | 12.08 | 13.82 | -5.64 | 14.13 | 12.61 |
| PAT Margin (%) | 8.02 | 10.35 | -2.50 | 8.11 | 8.84 |
| PAT After MI And SOA Margin (%) | 8.02 | 10.35 | -2.50 | 8.11 | 8.84 |
